PFIZER CEO ALBERT BOURLA is displeased by the legislative sprint to pass the Inflation Reduction Act, the sweeping energy bill financed in part by reductions in the price of key pharmaceuticals.
“I want to say it is very disappointing that they are choosing to single out one industry,” Bourla said during a call with investors last week.
The legislation, said Bourla, includes “specific measures to affect only the pharma industry, particularly when we are out of a pandemic, where this industry has proven the value that brings to public health and to the global economy.”
Comments